Never Give Up—Fight Illness With Strength And Science
An 83-year-old man with advanced Diffuse Large B-Cell Lymphoma chose fenbendazole, a deworming drug, over chemotherapy due to side effects. His condition improved over nearly a year, but experts caution that this case is not proof of efficacy. Standard cancer treatments remain essential, highlighting the need for medical guidance.
The article discusses a case report of Filipino workers in Taiwan who developed Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) after taking Metronidazole and Mebendazole. Even when taken weeks apart, these medications can pose serious risks. It emphasizes avoiding self-medication and consulting doctors to prevent severe reactions.
Updated on December 4, 2025, with new Latin American Spanish and Mandarin audio versions to help readers worldwide access this content. 🎧 ▶️ Press the play button below to listen in English. Your browser does not support the audio element. 🇪🇸 Spanish (Latinoamérica) En este audio conocerás los casos clínicos que han reportado lesión hepática…
A mouse study found that fenbendazole—a pet dewormer—makes Tylenol far more toxic to the liver. While not yet proven in humans, this combo could be risky. Avoid mixing these drugs!
This article details a case report of patients developing rare, life-threatening Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) after taking Metronidazole and Mebendazole—even when administered six weeks apart.
A recent case report highlights a patient with chemotherapy- and radiation-resistant adrenocortical carcinoma (ACC), an aggressive endocrine cancer, who achieved significant tumor regression following treatment with mebendazole—a repurposed antiparasitic drug.
This article discusses a case report of a man who took mebendazole to treat chemotherapy-resistant metastatic colon cancer—and survived.
This article discusses a published case report of a person who has large B-cell lymphoma who went into remission after taking fenbendazole.
This article discusses two studies that show the potential of benzimidazoles, typically used as an antiparasitic drug to treat intestinal cancers.
This article discusses the potential use of mebendazole for brain cancers. Finding new uses for existing drugs is an exciting and cost-effective way to improve treatments for challenging diseases. One such breakthrough involves Mebendazole (MBZ), a drug initially approved by the FDA to treat intestinal worm infections. Recent research has revealed that MBZ has significant…
This article discusses two studies identifying the potential use of mebendazole for cisplatin -resistant ovarian cancer.
This article is from a 2010 study about how benzimidazoles can be useful in drug-resistant, metastatic prostate cancer.
This article discusses a study that shows the potential effectiveness of using mebendazole for the treatment of triple-negative breast cancer with brain metastasis.
This article discusses two studies showing the potential use of mebendazole to make radiation treatment of triple-negative breast cancer more effective.
This article is about the potential use of mebendazole for the treatment of triple-negative breast cancer.
This article explores the potential of the antiparasitic drug mebendazole as a cancer treatment, detailing its dosing, safety profile, and effectiveness.
